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Alzheimer’s disease-like paired helical filament assembly from truncated tau 
protein is independent of disulphide cross-linking. 
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Abstract 
 
Alzheimer’s disease is characterised by the self-assembly of tau and amyloid  proteins 
into oligomers and fibrils. Tau protein assembles into paired helical filaments (PHFs) 
that constitute the neurofibrillary tangles observed in neuronal cell bodies in individuals 
with Alzheimer’s disease. The mechanism of initiation of tau assembly into PHFs is not 
well understood. Here we report that a truncated 95-amino acid tau fragment 
(corresponding to residues 297-391 of full-length tau) assembles into PHF-like fibrils in 
vitro without the need for other additives to initiate or template the process. Using 
electron microscopy, circular dichroism and X-ray fibre diffraction, we have 
characterised the structure of the fibrils formed from truncated tau for the first time. To 
explore the contribution of disulphide formation to fibril formation, we have compared 
the assembly of tau(297-391) under reduced and non-reducing conditions and for 
truncated tau carrying a C322A substitution. We show that disulphide bond formation 
inhibits assembly and that the C322A variant rapidly forms long and highly ordered 
PHFs.  
 
Highlights 
 Truncated tau is a major component of paired helical filaments (PHF) in 
neurofibrillary tangles in Alzheimer’s brain tissue and encompasses the core 
structure of PHF isolated from AD brain. 
 Truncated tau (297-391) forms filaments that share fine structural 
characteristics with isolated PHF. 
 Reduction of the disulphide, or replacement of Cys with Ala in truncated tau, 
leads to enhanced filament formation. 
 Truncated unmodified tau is sufficient for the assembly of PHF found in 
Alzheimer’s disease 
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disulphide. 
 
Introduction 
 
Alzheimer’s disease is characterised by the intracellular accumulation of insoluble 
neurofibrillary tangles composed of the tau protein, and the extracellular deposition of 
amyloid plaques. Amyloid plaques are composed predominantly of the amyloid beta 
peptide (A) [1] whilst neurofibrillary tangles are composed of paired helical filaments 
(PHFs), consisting of a truncated fragment of tau protein restricted to the repeat domain 
[2]. Tau and Apeptides self-associate in vitro to form fibrils that share a cross- core 
[3, 4]. Oligomeric species of tau have been implicated as being important in the 
characteristic spread of neurofibrillary degeneration throughout the brain and for the 
toxic effects leading to neuronal dysfunction and death [5, 6].  Several lines of evidence 
point to the importance of neurofibrillary tau pathology being closely associated with 
dementia in Alzheimer’s disease (AD) and other tauopathies [7-13].  
 
Tau protein, encoded by the MAPT gene, is expressed in the central nervous system as a 
family of six isoforms. These arise by alternative mRNA splicing and vary in length and 
in the content of three or four tandem repeats of 31 or 32 amino acids in the C-terminal 
domain [14]. Microtubules are essential in morphogenesis, cell division, and 
intracellular trafficking of organelles. At physiological concentrations, tau proteins 
stabilize microtubules as tracks for intracellular transport, but in excess they interfere 
with axonal transport [15]. Tau is also implicated in a number of other cellular 
functions, such as signal transduction, actin interaction and in the binding 
pericentomeric chromatin in the nucleus [16, 17]. In Alzheimer’s disease and other 
tauopathies, tau self-assembles through the repeat domain to form PHFs and straight 
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filaments.  Structural characterisation of PHFs isolated from AD brain tissue has 
revealed that the fibres display a distinct organisation of paired filaments that twist [18] 
or remain straight [3, 19, 20]. These filaments are also known to share the structural 
characteristics for amyloid, such as long unbranching filaments, high -sheet content 
and they display the characteristic cross-pattern by X-ray fibre and electron 
diffraction [3]. 
 
Several groups have investigated the assembly of full-length tau in vitro using other 
polyanionic molecules, such as heparin, RNA or proteoglycans, to nucleate assembly 
[21-23]. The tau species making up the proteolytically stable structural core of the PHF 
and its oligomeric precursors are derived from a mixture of fragments derived from 
both three- and four-repeat isoforms, but restricted to the equivalent of three repeats in 
length with distinct species originating from the three- and four-repeat isoforms of tau 
[24]. Two of the fragments from the 3- and 4-repeat isoforms terminate at the C-
terminus at Glu-391, with an N-terminus at amino acid 297. The third derives from the 
first 3 repeats of the 4-repeat isoform and has N- and C-termini at homologous positions 
[24, 25]. The fragments terminating at Glu-391 can be detected specifically by the 
antibody mAb423 [26] which has been shown to bind to intra- and extracellular NFTs in 
AD brain tissue [27], [25, 28]. The features of these 95-amino acid long fragments 
represent the footprint of the pathological tau–tau binding interaction which locks the 
repeat domains into a characteristic proteolytically stable configuration and one that is 
abnormally phase-shifted with respect to the tubulin-binding domains in this region of 
tau [25]. This templated prion-like interaction propagates and is amplified through 
repeated proteolytic digestion cycles [2] and can be modelled within the cell milieu [29]. 
Full-length and truncated tau bind to the core tau fragment with an estimated KD of 20 
nM, and binding is inhibited 10-50 fold by phosphorylation [30].   
Recently, a cryo-electron microscopy structure of PHFs isolated from AD brain has been 
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reported [31]. The core structure of these filaments is from 306 to 378 and the structure 
can incorporate both 3- and 4 repeat tau isoforms. The structure is an in-register 
parallel -sheet formed by a -bend and -helix motif, linked by  -strands [31]. 
 
In this study, we have used the truncated PHF-core tau fragment, based upon the core of 
the PHF [18, 32] and which includes the PHF core region identified in the recently 
reported PHF structure [31].  The truncated fragment comprises 95-amino acids 
corresponding to residues 297-391 from the 441-residue tau isoform (4R2N). It is 
termed dGAE; where d identifies the N-terminal residue 297 and GAE, the three C-
terminal residues terminating with Glu-391, as described in detail in [25]). dGAE was 
examined under non-reducing and reducing conditions. The 95-amino acid peptide 
contains a single cysteine at position 322 and we have compared the assembly of wild-
type dGAE with protein in which the Cys has been substituted with Ala (dGAE-C322A). 
The dGAE protein self-assembles into filaments that share the characteristics of amyloid 
(-sheet content, cross- X-ray fibre diffraction pattern) and that closely resemble the 
PHFs isolated from AD brains. We have investigated the contribution of disulphide 
formation of Cys322 and show that incubation in reducing conditions or introducing a 
C322A substitution lead to enhanced self-assembly and the production of long and 
highly ordered PHFs. 
 
Results 
 
Assembly of truncated tau protein 
Recombinant truncated dGAE tau and dGAE-C322A were expressed in bacteria and 
purified by ion-exchange chromatography. Purified, soluble dGAE (100 M) was 
incubated in phosphate buffer, with and without 10 mM DTT. dGAE-C322A was 
prepared in the same manner (without DTT) and assembly into aggregates or filaments 
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was monitored using thioflavin-S (ThS) fluorescence at intervals up to 48 h (Figure 1).  
ThS has been previously shown to give an enhanced intensity when measuring tau 
assembly [33] and used to quantify PHFs [29]. ThS fluorescence intensity for reduced 
and non-reduced dGAE and dGAE-C322A increased with time indicating the gradual 
assembly into oligomers and filaments (Figure 1a). ThS assays are very similar to ThT 
and will detect assembled structures above a certain threshold (depending on 
concentration). As has been shown frequently, ThT and ThS begin to show a signal at 
time points where small oligomeric structures can be observed by electron microscopy. 
The elongation of the fibrils correlates with an increase in fluorescence intensity.  
Indeed, we detect small oligomers by TEM at the same time point as an increased ThS 
intensity. Each spectrum showed a similar lag-phase length; the final intensity of ThS 
fluorescence for dGAE-C322A after 48 h was slightly lower than for dGAE. This may 
reflect subtle changes in binding of ThS to the different species formed. Tyrosine 
fluorescence was monitored to follow changes in the environment of the tyrosine 
residue during assembly, and again the data suggests similar assembly rates for non-
reduced dGAE and dGAE-C322A. In the presence of DTT, the tyrosine fluorescence 
decreased more rapidly, consistent with an alternative assembly pathway. Circular 
dichroism (CD) spectra showed that the dGAE transitioned from a mainly random coil 
conformation, with a minimum at 198 nm, to one of increasing -sheet conformation 
and reduced random coil (Figure 1c). Random coil dominates the signal in the whole 
sample, so to investigate this further, samples were centrifuged at 20,000 x g to separate 
the supernatant and pellet and CD was performed on the separated samples (Figure 1c). 
This revealed that the suspended pellet contains protein showing a strong red-shifted -
sheet signal with a minimum at 226 nm whilst the supernatant contains protein that is 
predominantly random coil with a strong minimum at 197 nm.  Under reducing 
conditions, dGAE gave a similar spectral profile to non-reduced dGAE.  dGAE-C322A 
gave a very weak random coil signal in the supernatant fraction, suggesting a reduction 
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in available soluble random coil protein. The spectrum from the dGAE-C322A pellet was 
unusual and contained minima at 194 nm and 230 nm. To ensure that this did not arise 
from alignment of fibrils giving rise to linear dichroism [34], the cuvette was rotated 
90°. The spectra were very similar, suggesting that this spectral difference does arise 
from CD. A red-shifted signal to 230 nm for -sheet has been observed previously for 
elongated amyloid fibrils made from -synuclein and may arise from extended lengths 
of -structure in long fibrils [35]. To compare the assembly of dGAE, dGAE with DTT and 
dGAE-C322A and to complement the results of ThS and tyrosine fluorescence, the 
intensity of the CD signal for the supernatant only, was plotted against time (Figure S1). 
These results suggest that dGAE-C322A variant assembles more quickly than dGAE 
under reducing conditions and that both assemble more quickly than dGAE alone. 
Centrifugation of the samples results in difficulties in measuring protein concentrations 
in pellet and supernatant. Therefore, BCA assay was used to compare the concentration 
of protein in the pellet and supernatant for dGAE and dGAE-C322A after incubation of 
48h (Figure S2). The results confirmed that less dGAE C322A remains in the supernatant 
compared to dGAE, supporting the view that C322A assembles more effectively than 
dGAE.  
 
 
Figure 1. Assembly of dGAE (100 M) incubated in non-reducing and reducing conditions 
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(with 10 mM DTT) and dGAE-C322A (100  in PB (10 mM; pH7.4).  a) Thioflavine S 
fluorescence assay showing assembly of all three samples over 48 h.  b) Fluorescence from 
tyrosine decreases over time during assembly suggesting a change in the environment of 
the tyrosine side-chain.  Data expressed as mean ± S.E. (n = 3).  c) CD spectra of non-
reducing and reducing dGAE and dGAE-C322A over time for the whole sample (top) and in 
the separated supernatant and pellet fractions (below). The whole samples show a 
reduction in intensity of the random coil signal (198 nm minimum) (see Figure S1) and a 
relative increase in intensity at 218 nm with increased time.  Following separation, 
random coil was observed in the supernatant and -sheet in the pellet. For the separated 
samples, the y axis is given in millidegrees as the unknown concentrations did not allow for 
conversion to molar ellipicity. 
 
Transmission electron microscopy (TEM) was performed to compare the morphology of 
the dGAE samples at time points from 0 to 48 h (Figure 2). Assembly of dGAE was 
observed under non-reducing conditions showing the formation of small round particles 
which developed into slightly elongated and laterally associated fibres after 10 h 
incubation and which did not elongate further by 48 h. In contrast, dGAE incubated with 
DTT under reducing conditions formed distinct fibrillar structures by 4 h, which 
continued to elongate up to 48 h.  dGAE-C322A formed elongated structures by 4 h, and 
numerous long fibrils by 24 h which associated laterally by 48 h. The ThS fluorescence 
assay suggested that the assembly kinetics were similar for the three protein samples 
(Figure 1a). However, TEM revealed significant differences in elongation and 
morphologies at the incubation time points examined (Figure 2). 
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Figure 2.  TEM of dGAE (100 M) incubated in non-reducing and reducing conditions 
(with 10 mM DTT) and dGAE-C322A (100  in PB (10 mM; pH7.4). dGAE assembles 
slowly to form small elongated fibres whilst reduced dGAE forms fibrils by 10 h incubation. 
dGAE-C322A forms long fibrils that associate laterally by 48 h. Scale bars, 200 nm. 
 
SDS-PAGE was conducted on samples treated in the same way as for fluorescence assays 
and TEM (Figure 3).  The whole sample was compared with separated supernatant and 
pellet fractions.  dGAE ran as a doublet with mobilities of 10/12-kDa and a doublet with 
mobilities of 20/24-kDa (see Figure 3a insert). Since the dGAE fragment has a 
theoretical molecular weight of 10.27 kDa, 10 kDa is likely to represent the monomer 
and 20 kDa, the corresponding dimer. The 12- and 24-kDa species are likely to 
represent alternative folding configurations of the dGAE monomer and dimer, 
respectively, having retarded gel mobility. After 48 h, the intensity of the bands in the 
whole sample was decreased and the bands in the supernatant appeared to be similar, 
but with markedly decreased dimer content. The pellet was enriched selectively for the 
12- and 24-kDa species as well as for some weaker bands migrating at 37-50 kDa, 
suggesting the presence of higher molecular weight oligomers. The data suggest that the 
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dGAE fragment is able to exist in two SDS-resistant conformations with different gel 
mobilities both as monomers and as dimers. The selective enrichment in the pellet of the 
12- and 24-kDa species suggests that only one of the two conformations of dGAE is 
competent to aggregate into fibrils. To confirm that dGAE with DTT remained reduced 
following incubation for 48h, free thiols were detected using Iodoacetimide-Oregon 
Green 488 (IAA-OG) assay (see Supplementary information for methods). The results 
confirmed that the cysteine thiols remained free following incubation (Figure S3).  
Immunoblotting was conducted using T22, an oligomer-specific antibody [36] to gain 
more information about the different mobility species.  T22 bound selectively with the 
12- and 24-kDa species in the pellet, but not with the more abundant 10-kDa monomer 
present in the supernatant. T22 also labelled higher-molecular weight species at around 
50 kDa in the pellet.  
 
 
Figure 3. SDS-PAGE and immunoblot of dGAE (100 M) in (a) non-reducing and (b) 
reducing conditions (with 10 mM DTT) and (c) dGAE-C322A (100 M). Each set of panels 
shows the results of Coomassie blue-stained SDS-PAGE gels (left) and immunoblot, using 
T22 anti-tau oligomer antibody (right), for the entire sample (whole) and the fractionated 
supernatant (sup) and pellet. Figure 3a shows an insert to highlight the positions of the 
doublet bands with reduced intensity.  (d) Dot immunoblot for protein samples developed 
using T22 [36]. 
 
dGAE incubated under reducing conditions produced  intense 10- and 12-kDa monomer 
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bands at 0 and 48 h, but less of the corresponding dimers than seen in the absence of 
DTT. Coomassie blue staining also revealed non-migrating species of very high 
molecular weight species in the wells. The monomer band remaining in the supernatant 
was substantially reduced and restricted to the species with 10-kDa mobility. The pellet 
contained both monomeric and dimeric species, corresponding exclusively to the 12- 
and 24-kDa variant. Comparison of these gels with those from non-reduced dGAE 
preparations suggests that the prevention of disulphide bond formation by the 
incubation with DTT facilitates the aggregation of the 12- and 24-kDa assembly-
competent variants, leaving the 10-kDa monomer in the supernatant fraction. Also, 
incubation with DTT favours the formation of very high molecular weight species which 
are either SDS-insoluble or too large to enter the gel. Interestingly, western blotting 
again revealed preferential binding of T22 to the 12- and 24-kDa species, and not the 
10- and 20-kDa variants seen by Coomassie staining in the whole preparation and in the 
supernatant fraction.  
 
dGAE-C322A (Figure 3) showed a predominant 12-kDa monomer and a less intense 10-
kDa monomer at 0 h. After 48 h, the 12-kDa species was enriched in the pellet and the 
10-kDa species enriched in the supernatant. Dimer formation was less than seen either 
for native dGAE fragment or following incubation in DTT, and again corresponded to the 
24-kDa species. Immunoblotting showed that T22 reactivity was restricted to the 12-
kDa species in the pellet with no binding to the 10-kDa species predominating in the 
supernatant fraction at 48 h.  As a control, dGAE-C322A was also separated by SDS-
PAGE in the presence of DTT and no change in the mobility was observed (data not 
shown). 
 
In contrast to samples separated by SDS-PAGE, dot immunoblotting showed reactivity of 
T22 to in all three samples at 0 h and this is likely to correspond to the 12 kDa species. 
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The intensity of T22 binding reduced after 48h incubation in the whole and supernatant 
sample and there was no binding of T22 to the pellet (Figure 3b). This suggests that the 
12-kDa band is in an oligomer-like conformation and that, following filament assembly, 
there is occlusion of the T22 epitope(s) leading to loss of T22 binding. 
 
Collectively, the results of ThS, Tyrosine fluoresence, TEM and SDS PAGE show that Cys-
322 is unnecessary for filament assembly and that reduction of disulphide bonds, or 
substitution of Cys with Ala, promotes assembly to form longer and larger fibrillar 
structures which sediment at low speed and that these are composed predominantly of 
the 12-kDa variant. Furthermore, the formation of a dimer in reducing conditions is 
suggestive of an alternative SDS-insoluble bond being formed in dGAE [37]. One 
possibility is the formation of dityrosine, which remains stable in reducing conditions 
[38]. 
 
 
Figure 4. X-ray fibre diffraction patterns from partially aligned fibrils. dGAE (100 
M) incubated in non-reducing and reducing conditions (with 10 mM DTT) and dGAE-
C322A (100  in PB (10 mM; pH7.4) washed in milliQ water before alignment. The 
insert highlights the diffraction signals for dGAE-C322A to show the position of 28 Å 
equatorial signal. 
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X-ray fibre diffraction was performed for fibrils formed after 48 h incubation and 
revealed that all three proteins were able to form cross- structures characteristic of 
amyloid fibrils (Figure 4).  The diffraction patterns shared a sharp, strong 4.7 Å and a 10 
Å reflection, although the pattern from dGAE was poorly aligned due to the short fibrous 
structures formed. However, the diffraction pattern from dGAE-C322A showed a well-
aligned fibre diffraction pattern with clear 4.7 Å reflection on the meridian and 9.5 Å 
reflection on the equator. A low-angle diffraction signal close to the backstop was also 
observed at approximately 28 Å, which may arise from ordered packing of the filaments 
(Figure 4 insert). The patterns collected from the three fibre samples were very similar, 
and no obvious differences can be inferred from the patterns.  
 
At 100 M, dGAE forms only relatively short fibrillar structures even after incubation of 
up to 48 h. To investigate whether there is a concentration dependent effect leading to 
different fibril morphologies, dGAE was incubated at increasing concentrations from 
100 M to 400 M. 
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Figure 5. Characterisation of dGAE fibrils. Fibrils were formed using different starting 
concentrations of protein, as indicated, and incubated at 37 oC with agitation (700 rpm) 
for 48 h in PB (10 mM; pH7.4). a) Comparison between the CD spectra of supernatant and 
pellet fractions for each concentration of dGAE.  The y axis is given in millidegrees as the 
concentrations did not allow for conversion to molar ellipicity. The intensity at 198 nm 
increased with increasing concentration (see Figure S4).  b) dGAE fibril morphologies by 
TEM. Scale bars, 200 m (increased magnification panels included to highlight 
morphologies). c) X-ray fibre diffraction patterns from partially aligned filament samples 
formed by dGAE, at the starting concentration indicated, showing the classic “cross-” 
pattern. (4.7 Å meridional is labelled with black arrow and 10-11 Å equatorial, with white 
arrow). Fibre axis is approximately vertical for all diffraction patterns. 
 
CD was used to examine the secondary structures of the dGAE at different 
concentrations in the separated supernatant and pellet fractions. The CD spectra of the 
supernatant indicated the presence of random coil structure and signal intensities at       
-198 nm increased with concentration (Figure S4) suggesting that a proportion of 
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protein remains in solution.  However, the CD spectra of dGAE pellet from different 
starting concentrations varied considerably. All spectra were consistent with a -sheet 
conformation, but the positions of the minima differed slightly, probably reflecting 
differences in the super-secondary structural content of the filamentous structures in 
the pellet (Figure 5a). ThS fluorescence was measured over 24 h and assembly rates for 
dGAE at low and high concentrations were compared. The findings suggest that the 
elongation rate increased with increased starting protein concentration (Figure S5). 
TEM analysis showed changes in the lateral association and twisting of the filaments. 
Longer fibrils were observed at 250 M concentration, and at 300 M, only long fibrils 
were observed whilst the smaller elongated particles were absent. At the highest 
concentration of dGAE tested (400 M), highly ordered filaments with a clearly paired 
arrangement and a regular twist were observed (Figure 5b). The mean (±SD) width was 
16.18 ±1.59 nm and 7.61±1.24 nm with an approximate periodicity of 73.3 ± 4.37 nm 
(distributions shown in Figure S6). 
 
In order to investigate whether the molecular architecture of the filaments was 
dependent on concentration, X-ray fibre diffraction data were collected from all fibre 
samples prepared over a range of concentrations. Partially aligned fibre samples all 
exhibited characteristic cross- diffraction signals (Figure 5c; white and black arrows). 
The patterns were very similar to one another with some small differences in alignment 
of the meridional and equatorial diffraction signals. TEM reveals differences in lateral 
packing and length but X-ray fibre diffraction reveals that the core structures were 
similar in all samples and consistent with the classical cross- structure within the 
protofilaments core [39].  
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Figure 6. TEM and X-ray fibre diffraction of non-reduced and reduced dGAE at 400 
M. a) Electron micrographs showing the twisted features of the dGAE filaments after 
incubation of 24 and 48 h, each shown at 10k and 25k magnification. Scale bars, 200 nm 
with selected inserts showing 4x magnification. b) Diffraction pattern obtained from dGAE 
(400 M) without and with DTT. 
 
TEM and X-ray fibre diffraction were used to explore further whether there are any 
structural differences between dGAE incubated in non-reducing and reducing conditions 
at high concentrations (400 M) (Figure 6).  TEM showed that dGAE under both 
conditions forms paired-helical filaments that have a helical periodicity of around 80 
nm. This is similar to the helical periodicity observed for PHF isolated from AD tissue 
[18, 32] [40, 41]. The truncated protein was able to form straight, paired filaments as 
well, although these were less common than the PHF morphology (approximately 10:90 
ratio of SF to PHF) (see Figure S7).  Straight filaments extracted from AD brain tissue 
constitute 5% of filaments [42]. X-ray fibre diffraction data showed the expected cross-β 
diffraction signals, but alignment was insufficient for further analysis. This is likely to be 
due to the very long filaments tangling and preventing good fibre orientation. However, 
the patterns show no evidence of any obvious differences between samples incubated 
with or without DTT. 
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Further analysis of the morphologies found in non-reduced and reduced dGAE samples 
are shown in Figure 7. Non-reduced dGAE formed a majority of PHFs with a helical 
repeat of 73.3 ± 4.37 nm, whilst reduced dGAE formed PHFs with a helical repeat of 65.0 
± 6.9 nm and diameters of 17.8±1.19 nm (wide) and 10.09±2.42 nm (narrow). 
Occasionally, wider filaments were observed with a diameter of 20 nm, which appeared 
to be composed of more than one pair of filaments twisted together (Figure 7). Fewer 
filaments with longer repeats of 83 nm were also observed. Overall, although the two 
samples contained a range of different species, there was no strong evidence to suggest 
that the structures were different when dGAE was incubated under non-reducing or 
reducing conditions. dGAE-C322A formed twisted ribbons consisting mostly of two 
protofilaments and with variable repeat lengths 392.5±32.9 nm and occasionally, single 
protofilaments were observed (see Figure 7). 
 
Figure 7. Electron micrographs showing the detailed morphology of the dGAE 
assembled under non-reducing conditions, reducing conditions (400 M) and dGAE-
C322A (100 M). Each condition yields paired helical filaments and some straight 
filaments. There is very little difference between the morphology of dGAE assembled under 
non-reducing and reducing conditions, whereas dGAE-C322A formed twisted ribbons 
consisting of paired protofilaments. Scale bars shown in nm. 
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Discussion 
In this study, we have shown that a truncated form of tau corresponding to a 95-amino 
acid region of the C-terminal domain (dGAE) is able to form filaments at physiological 
pH in the absence of any additives and that these closely resemble the PHFs found in 
neurofibrillary tangles in AD brain tissue. The dGAE fragment matches two of the 
species making up the structural core of the PHFs isolated from AD brain tissues [2]. 
Using a range of biophysical and structural approaches, we have shown that dGAE 
assembles in a concentration-dependent manner, with increasing -sheet content and 
sharing the cross- structure characteristic of all amyloid fibrils.  Interestingly, small 
variations in the concentration of the protein leads to changes in the macromolecular 
appearance of the fibrils based upon electron microscopy observations and CD spectra. 
This highlights that very minor differences can have a large effect on the packing and 
overall morphology of filaments. Indeed, it has been shown that tau forms different 
filament morphologies when isolated from brain from different tauopathies, giving rise 
to different structural “strains” [40]. However, X-ray fibre diffraction indicated that the 
core cross- structure was unaffected by these variations in macromolecular assembly.  
 
We report that the assembly of the truncated core-tau fragment was enhanced by 
reducing conditions and the protein was able to form longer fibrils at the same 
concentration. To further explore the contribution of disulphide bond formation, we 
examined the assembly of dGAE-C322A and found that a species lacking any cysteine 
residues assembles rapidly and forms long, twisted filaments. The role for disulphide 
links in assembly has previously remained unclear as it has been impossible to study the 
effect of disulphide links on assembly in the absence of polyanionic additives, such as 
heparin, using full-length recombinant tau preparations [43]. We reveal that tau is able 
to form two types of dimer, one cysteine dependent and the other, cysteine independent. 
Full-length tau in COS cells has been previously shown to form cysteine dependent and 
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independent dimers. Variants of full-length tau (C291A/C322A) that do not contain 
cysteines are able to form fibrils [43]. Furukawa argued that the morphologies of 
filaments assembled from full-length tau can be determined by disulphide status and 
thioflavine T fluorescence and that disulphide-linked tau assembled more readily [44]. 
However, electron microscopy showed that the filaments formed with disulphide bonds 
were shorter than those formed in the presence of DTT, similar to our findings. The K18 
fragment (a different truncated four-repeat tau fragment; tau244-372) is able to form an 
intra-molecular disulphide-linked monomer which is not assembly-competent [45].  
 
Our studies suggest that a truncated tau fragment corresponding to that found in the 
proteolytically stable core of the PHF exists in two alternative monomeric isoforms, one 
with a gel mobility of 10 kDa corresponding to the theoretical molecular weight of the 
fragment and a corresponding dimer of 20 kDa. The second has a gel mobility 
corresponding to 12 kDa and a corresponding dimer of 24 kDa. Exactly the same doublet 
was seen in the protein extracts from the PHF-core which first permitted the 
identification of a truncated tau protein fragment as a structural constituent of the PHFs 
formed in AD [2]. The formation of the 12-kDa variant does not depend on disulphide 
cross-links, since it can form in the presence of an excess of DTT and also if there is a 
C322A substitution to produce a species lacking any cysteine residues.   
 
The formation of the 20-kDa dimer was seen only in preparations favourable to 
disulphide bridge formation using native preparations of the dGAE fragment. 
Furthermore, the 10- and 20-kDa forms are enriched in the residual supernatant 
fraction left after filament assembly, whereas the 12- and 24-kDa forms are enriched 
selectively from the preparations of large aggregates isolated from slow-speed pellets. 
Conditions that inhibit filament assembly at low concentration (native dGAE at 100 M), 
with formation of elongated spherical particles and short fibres at low concentration 
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(100 M), are also conditions favouring the formation of the 20-kDa dimer. The addition 
of a reducing agent (DTT) to the assembly solution results in the ability of the short, 
fibrillar dGAE structures to elongate to form long twisted fibrils. Furthermore, 
preventing the formation of disulphide bonds by replacing the only Cys residue in dGAE 
with Ala leads to the rapid formation of very long fibres. Increasing dGAE concentration 
leads to formation of long twisted fibrils, suggesting that at sufficiently high 
concentration species with disulphide crosslinks no longer affect the elongation step 
and that it is possible to overcome the inhibition associated with formation of 
disulphide dimers. We suggest that, at high concentration, the nucleation process is 
faster than when the protein contains disulphide bonds. Since there are no obvious 
differences in morphology or structure of the filaments forming from native dGAE at 
high concentration and those forming in conditions which prevent the formation of 
disulphide bonds, it is likely that there is a common assembly-competent precursor 
conformation and that the resulting PHFs do not contain any significant amounts of 
disulphide-linked dGAE. We hypothesise that formation of assembly-incompetent 
dimers via disulphide linkages compete at the binding sites required for filament 
assembly thereby limiting their extent. From this interpretation, conditions 
unfavourable to disulphide bridge formation would facilitate the formation of the 
assembly-competent variant and prevent other binding interactions with assembly-
incompetent dimers which impede the formation of long PHF-like filaments (Figure 8). 
 
Our findings are consistent with the view that disulphide bond formation impedes PHF 
assembly. It has been shown that intramolecular disulphide bond formation stabilises 
aggregation-prone tau peptides in conformations inconsistent with the formation of 
cross-β-structure [45]. Our findings are therefore at odds with the proposal that 
disulphide-linked dimer formation is a critical step in the pathological aggregation of tau 
protein in AD [44, 46-48]. It is also at odds with the proposal that the tau aggregation 
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inhibitor methylthioninium chloride (MTC) acts by preventing disulphide bridge 
formation [49, 50]. Our data imply that if MTC were indeed able to impede cysteine 
cross-linking, it would have the effect of enhancing filament formation, which is not the 
case in cell-free or cell-based models or in disaggregation of PHFs isolated from AD 
brain tissue [29, 51]. Further studies aiming to elucidate the correct mechanism of 
action of MTC are in progress.  
 
 
 
 
 
Figure 8. Schematic showing the role for disulphide bonding in assembly. The 
initial dGAE solution contains monomers. At low concentration, the dGAE protein is able to 
form disulphide-linked dimers and with agitation, to elongate to form short filaments 
which cannot elongate further. This prevention of elongation can be overcome by the 
addition of DTT, which prevents formation of disulphide bonds and leads to the formation 
of an assembly competent intermediate that can elongate to form long PHFs.  At high 
concentration of dGAE in non-reducing conditions, there is competition between formation 
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of assembly competent and incompetent forms and long filaments can be formed. dGAE-
C322A is unable to form disulphide bonds and is able to assemble rapidly to form long PHF.  
 
Overall, our results show that the dGAE fragment is able to form two different species in 
solution under non-reducing conditions, an assembly-competent form and an assembly-
incompetent form. It is striking that the 12/24-kDa variant is simultaneously enriched 
in the pellet and depleted from the supernatant after 48 h incubation in conditions 
which reduce disulphide bridge formation and which also enhance the formation of long 
fibres which closely resemble PHFs isolated from AD brain tissue [18, 31, 32] . It is also 
striking that it is the same variant which is preferentially recognised by the oligomer-
specific antibody T22. Our results suggest, therefore, that there exists a specific 
conformation present in the 12-kDa variant, which makes it immunologically distinct 
from the alternative form which migrates at 10-kDa. Filaments assembled from the 12-
kDa species have the same detailed morphological features as native PHFs isolated from 
AD brain tissue, including the characteristic longitudinal features in which four strands 
alternate with three-strands in the twisted ribbon configuration, and showing only four 
strands in the flattened ribbon configuration. These features reflect the presence of the 
repeating C-shaped first identified in the native PHF core [18, 32] and found also to be 
the repeating subunit of straight filaments [42]. It has been reported recently that the C-
shaped subunit of the PHF core corresponds to a folded hairpin configuration of the core 
tau unit of the PHF matching closely the sequence of the dGAE fragment we have studied 
here [31]. In this structure, elucidated using cryo-EM analysis of ex-vivo PHF and SF, the 
tau folds into a cross-/ -helix structure in residues 306-378 [31] (Figure S8). The 
structure also reveals that the position of the Cys side chain is buried between two -
sheets and would not be available for disulphide linking with Cys from another molecule 
(Figure S8). This reinforces our findings that the disulphide linked dimer is assembly 
incompetent. We therefore infer from the data we have presented that the property of 
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assembly-competence that we have associated with the 12-kDa variant is directly linked 
with the hairpin conformation of the repeat domain found in the PHF core and 
recognised selectively by T22.  
 
Previous studies have shown that the tau unit corresponding to the dGAE fragment has 
the ability to bind full-length tau with high affinity and to template the reproduction of 
the core unit with loss of proteolytically susceptible domains outside the repeat domain 
in the presence of proteases [51]. The stable core of the PHF has a -sheet structure [3] 
whilst the fuzzy coat is thought be composed of unstructured protein chains [52] from 
the N- and C-terminal extensions of the molecule.  Although there is considerable 
heterogeneity in the morphology of the filaments formed, which we have shown to 
depend on duration of incubation and concentration, the diffraction patterns of the 
different forms suggests a common underlying -sheet molecular architecture. 
 
We hypothesise on the basis of these results that underlying β-sheet architecture is 
inherent to and located within the conformation of the assembly-competent 12-kDa 
species.  The property of dimerization shown on SDS-PAGE is not necessarily indicative 
of assembly competence, and indeed it is likely that formation of the 20-kDa dimer is 
associated with inhibition of filament assembly. Our findings suggest that the 
therapeutic goal of optimising inhibitors of tau aggregation may be served best by 
agents which either prevent the core tau protein fragment from adopting the assembly-
competent configuration, or which block the association of assembly of 12-kDa subunits 
into toxic oligomers and filaments. 
 
Materials and methods 
 
Assembly of truncated tau fibrils 
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Recombinant truncated tau (dGAE) and dGAE-C322A were expressed in bacteria and 
purified by P11 phosphocellulose chromatography as described previously [51, 53], 
with minor modifications.  In some cases, 2-(N-morpholino)ethanesulfonic acid (MES), 
pH 6.25, was used instead of piperazine-N,N'-bis(ethanesulfonic acid) (PIPES) and the 
protein was heat treated [54] instead of DE52 ion-exchange treatment prior to P11 
chromatography. Protein fractions were eluted with buffer (50 mM PIPES, pH 6.8 or 50 
mM MES, pH 6.25, both supplemented with 1 mM EGTA, 5 mM EDTA, 0.2 mM MgCl2, 5 
mM 2-mercaptoethanol) containing 0.1-1 M KCl.  The peak of protein elution was 
identified by protein assay (at 0.3-0.5 M KCl) and dialysed against either 80 mM PIPES 
buffer, pH 6.8, 1 mM EGTA, 5 mM EDTA, 0.2 mM MgCl2, 5 mM 2-mercaptoethanol or 
phosphate buffer (10 mM; pH 7.4). Protein concentration, measured using Advanced 
Protein Assay Reagent (Cytoskeleton, Inc.) with bovine serum albumin as a standard, 
was in the range 2.7-4.9 mg/ml. The protein was diluted to 10 mM phosphate buffer, pH 
7.4 at a range of concentrations (100 - 400 μM) for further analysis.  
 
Investigating the role of disulphide bond on dGAE assembly 
dGAE (100 μM) with and without DTT (10 mM) was incubated at 37 C with agitation at 
700 oscillations per min (Eppendorf thermomixer C, Epppendorf, Germany) for 48 h. dGAE-
C322A (100 μM) was incubated using the same assembly conditions. The assembly 
process was monitored using thioflavine S (ThS) fluorescence spectroscopy, tyrosine 
fluorescence spectroscopy, circular dichroism spectrometry (CD), negative stain 
transmission electron microscopy (TEM), X-ray fibre diffraction (XRFD), SDS-PAGE and 
immunolabelling dot blot. 
 
Transmission electron microscopy (TEM) 
Electron microscopy grids were prepared by placing 4 μl of sample onto 
formvar/carbon-coated 400-mesh copper grids (Agar Scientific), blotting excess and 
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then washing with 4 μl of 0.22 μM filtered milliQ water. Uranyl acetate (4 L of 2% w/v) 
was placed on the grid twice for one minute and then blotted and the grid allowed to air-
dry. Electron micrograph images were collected using a JEOL JEM1400-Plus 
Transmission Electron Microscope operated at 120 kV. Images were acquired digitally 
with an axially mounted (2000 × 2000 pixel) Gatan Ultrascan 1000 CCD camera. 
 
Circular dichroism (CD) 
CD was performed using a Jasco Spectrometer J715 and spectra collected in triplicate at 
a maintained temperature of 21 °C.  Protein samples (30 and 60 μl) were placed into 0.1 
and 0.2 mm path length quartz cuvettes (Hellma), respectively, and scanned from 180-
300 nm.  Since the CD spectra were dominated by a random coil signal, samples were 
centrifuged at 20,000 g for 30 min to separate fibrillar structures from the mixture. CD 
was then determined on the supernatant and pellet fractions (40 μl) separately. CD data 
was converted into molar ellipticity (deg.cm2.dmol-1) where concentrations were 
known. 
 
Tyrosine fluorescence 
Spectra were collected for dGAE, dGAE with 10 mM DTT, dGAE-C322A (140 μl, 100 μM) 
in a 10-mm cuvette. The excitation wavelength was 280 nm and an emission scan 
between wavelength 290-500 nm was collected using a Varian Cary Eclipse 
Fluorescence Spectrophotometer. The sample compartment was set to 21 ◦C with a scan 
rate of 600 nm/min. The data represent three independent experiments.  
 
Thioflavin S fluorescence.   
dGAE (20 μl) was mixed with ThS (280 μl, 5 μM) in 3-(N-morpholino)propanesulfonic 
acid (MOPS) (20 mM, pH 6.8) and then added to a 10-mm pathlength cuvette. An 
emission scan between 450-600 nm was obtained. The compartment was set to 21 ◦C 
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with a scan rate of 600 nm/min. The average of three spectra are used for each graph. 
 
SDS-PAGE and immunoblotting 
dGAE (100 µM; with or without 10 mM DTT) and dGAE-C322A were agitated at 700 
rpm, 37°C for 48 h. Aliquots of the whole assembly mixture were taken at 0 and 48 h. 
After 48 h agitation, the whole assembly mixture was centrifuged at 20,000 g for 30 
mins at 4°C. The resulting supernatant was separated from the pellet and the pellet was 
suspended in an equal volume of phosphate buffer (10 mM; pH 7.4). The entire 
assembly mixture and the supernatant and pellet fractions were used for SDS-PAGE and 
immunoblotting (3 l of each per lane). For SDS-PAGE, samples were mixed with SDS 
sample buffer (without reducing agent) and separated using a 4-20 % gradient Mini-
Protean® TGX Precast gels (Bio-Rad) at 120 V, until the sample buffer reached the end of 
the gel. The gel was stained using Imperial Protein Stain (Thermo Scientific), following 
the manufacturer’s instructions, before sealing the gel and scanning on a Canon 
ImageRunner Advance 6055i scanner. 
 
For immunoblotting, the separated proteins on the gel were transferred onto 
Amersham™ Protran™ NC nitrocellulose membrane (0.45 µm) at 200 mA for 90 min. 
The membranes were blocked in 5% milk in TBS-T (0.1% Tween-20) for 1 h rocking at 
room temperature. The membrane was incubated with T22, an antibody that recognises 
oligomeric tau (ABN454, Merck Millipore), in 5% milk in TBS-T (1:1000) overnight at 
4°C. The membrane was incubated in secondary HRP-conjugated goat anti-rabbit 
antibody in 5% dried milk in TBS-T (1:10,000) for 1 h at room temperature. The 
membrane was developed using Clarity™ ECL blotting substrate (Bio-Rad), following the 
manufacturer’s instructions, and then exposed to X-ray film.  The membrane was 
washed 5 x 10 min in TBS-T in between antibody incubations. 
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For the dot blot, 3 µl of the whole assembly mixture, the supernatant and pellets were 
blotted onto Amersham Protran NC nitrocellulose membrane (0.45 µm) and were left to 
air dry. The membrane was rinsed in TBS-T and then immediately blocked overnight at 
4°C in 5% milk in TBS-T. The membrane was incubated with T22 (1:1000) for 1 h at 
room temperature, followed by secondary HRP-conjugated goat anti-rabbit antibody 
(1:10,000) for 1 h at room temperature. The membrane was detected using Clarity ECL 
blotting substrate (Bio-Rad), following the manufacturer’s instructions, and then 
exposed to X-ray film.  The membrane was washed 5 x 10 mins in TBS-T between each 
antibody incubation. 
 
X-ray fibre diffraction 
Samples were prepared for X-ray fibre diffraction by incubating dGAE, dGAE with DTT 
and dGAE-C322A (diluted in 10 mM phosphate buffer, pH 7.4) for 48 h to allow 
formation of fibrils at 37 C and with agitation (700 oscillations per min). The resulting 
fibrils were collected by centrifugation (20,000 g), washed twice with water to remove 
buffer salts, and 10 l of the sample was placed between wax-tipped capillary tubes 
allowed to dry overnight or dried onto a Teflon slide as described previously [55]. The 
partially aligned samples were mounted on a goniometer head and a diffraction pattern 
was collected using a Rigaku rotating anode fitted with Saturn CCD detector, using an 
oscillation of 0.5°. Exposure times were 30 or 60 seconds and the specimen to detector 
distance was 50 mm or 100 mm, respectively.  Diffraction data were converted to TIFF 
format using Mosflm [56] and inspected using CLEARER [57].  Measurements of the 
diffraction signals were taken using the module within CLEARER and these were then 
entered into the unit cell determination module, to explore possible indexing of the 
diffraction signals to a unit cell.  
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Highlights 
 Truncated tau is a major component of paired helical filaments (PHF) in 
neurofibrillary tangles in Alzheimer’s brain tissue and encompasses the core 
structure of PHF isolated from AD brain. 
 Truncated tau (297-391) forms filaments that share fine structural 
characteristics with isolated PHF. 
 Reduction of the disulphide, or replacement of Cys with Ala in truncated tau, 
leads to enhanced filament formation. 
 Truncated unmodified tau is sufficient for the assembly of PHF found in 
Alzheimer’s disease 
